BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1920355)

  • 1. Synthesis and antitumor properties of activated cyclophosphamide analogues.
    Borch RF; Canute GW
    J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, activation, and cytotoxicity of aldophosphamide analogues.
    Borch RF; Valente RR
    J Med Chem; 1991 Oct; 34(10):3052-8. PubMed ID: 1920356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
    Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
    J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data.
    Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
    Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE; Landkamer GJ
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.
    Zaharko DS; Covey JM; Hörpel G
    Invest New Drugs; 1984; 2(2):149-54. PubMed ID: 6469508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
    Struck RF; Schmid SM; Waud WR
    Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of a series of ftorafur analogues: the effect of varying electronegativity at the 1'-position.
    Holshouser MH; Shipp AM; Ferguson PW
    J Med Chem; 1985 Feb; 28(2):242-5. PubMed ID: 3918171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antineoplastic activity of a novel series of phosphoramide mustard analogues of pyrimidine deoxyribonucleosides.
    Lin TS; Fischer PH; Prusoff WH
    J Med Chem; 1980 Nov; 23(11):1235-7. PubMed ID: 7452673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
    Sonawat HM; Leibfritz D; Engel J; Hilgard P
    Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 31P NMR and chloride ion kinetics of alkylating monoester phosphoramidates.
    Fries KM; Borch RF
    J Med Chem; 1991 Feb; 34(2):565-9. PubMed ID: 1995878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of cyclophosphamide analogues. 3. Preparation, molecular structure determination and anticancer screening of racemic cis- and trans-4-phenylcyclophosphamide.
    Boyd VL; Zon G; Himes VL; Stalick JK; Mighell AD; Secor HV
    J Med Chem; 1980 Apr; 23(4):372-5. PubMed ID: 7381836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
    Sladek NE; Low JE; Landkamer GJ
    Cancer Res; 1985 Feb; 45(2):625-9. PubMed ID: 3967238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
    Wang YQ; Farquhar D
    J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.